Skovronsky Daniel

CIK 0001741474

SVP, CS&MO & Pres. LRLDirector

Filings

Latest Feb 11, 2026

Issuers covered

Showing

19 of 19

Page 1

Track record

4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	4	100%	+8.6%	+5.4%	+18.3%	+5.4%
90 days	4	100%	+22.6%	+13.0%	+51.2%	+13.0%
180 days	4	100%	+36.0%	+26.9%	+63.4%	+26.9%
365 days	3	0%	-18.0%	-18.0%	-18.0%	-18.0%

Companies where Skovronsky Daniel has filed

Ticker	Issuer	Filings	Last filed
LLY	Eli Lilly & Co	15	Feb 11, 2026
MYGN	Myriad Genetics Inc	4	Jun 6, 2025

19 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 11, 2026	LLYEli Lilly & Co	AGrant	15,547.86	$1,044.67	$16,242,385
Feb 3, 2026	LLYEli Lilly & Co	FTax	5,641.25	$1,037.15	$5,850,821
Nov 10, 2025	LLYEli Lilly & Co	GGift	179	$0.00	$0
Aug 12, 2025	LLYEli Lilly & Co	PPurchase	1,000	$634.405	$634,405
Jun 6, 2025	MYGNMyriad Genetics Inc	AGrant	49,796	$0.00	$0
Feb 12, 2025	LLYEli Lilly & Co	AGrant	18,771.75	$868.88	$16,310,400
Feb 4, 2025	LLYEli Lilly & Co	FTax	4,003.64	$811.08	$3,247,272
Sep 12, 2024	LLYEli Lilly & Co	GGift	111	$0.00	$0
Jun 10, 2024	MYGNMyriad Genetics Inc	AGrant	15,695	$0.00	$0
Feb 14, 2024	LLYEli Lilly & Co	AGrant	12,910	$737.26	$9,518,027
Feb 2, 2024	LLYEli Lilly & Co	FTax	4,434	$645.61	$2,862,635
Nov 13, 2023	LLYEli Lilly & Co	GGift	17	$0.00	$0
Aug 11, 2023	LLYEli Lilly & Co	GGift	249	$0.00	$0
Jun 2, 2023	MYGNMyriad Genetics Inc	AGrant	15,151	$0.00	$0
Feb 14, 2023	LLYEli Lilly & Co	AGrant	18,388	$345.12	$6,346,067
Feb 3, 2023	LLYEli Lilly & Co	FTax	7,035	$344.15	$2,421,095
Jun 3, 2022	MYGNMyriad Genetics Inc	AGrant	17,275	$0.00	$0
Feb 11, 2022	LLYEli Lilly & Co	AGrant	22,581	$243.27	$5,493,280
Feb 3, 2022	LLYEli Lilly & Co	FTax	8,437	$245.39	$2,070,355

Showing 1-19 of 19

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.